EMD-25167

Single-particle
6.4 Å
EMD-25167 Deposition: 19/10/2021
Map released: 04/05/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-25167

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein

EMD-25167

Single-particle
6.4 Å
EMD-25167 Deposition: 19/10/2021
Map released: 04/05/2022
Last modified: 17/01/2024
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Antibody 11-11 in complex with prefusion SARS-CoV-2 B.1.351 Spike glycoprotein

Deposition Authors: Casner RG , Shapiro L
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses.
PUBMED: 35438546
DOI: doi:10.1126/scitranslmed.abn6859
ISSN: 1946-6242
Grant Support: